1980
DOI: 10.1111/j.1751-0813.1980.tb15982.x
|View full text |Cite
|
Sign up to set email alerts
|

Cambendazole Toxicity in Calves

Abstract: The death of 3 of 8 dairy calves was associated with the administration of 98.5 mg/kg cambendazole. Significant lesions consisted of marked pleural effusion, severe pulmonary oedema and necrotic lymphadenopathy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1985
1985
2013
2013

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 1 publication
0
3
0
Order By: Relevance
“…Seiler observed anaemia in dogs after prolonged treatment with TBZ [50]. In calves, treatment with cambendazole caused pulmonary oedema and necrotic lymphadenopathy, which was fatal in some cases [51].…”
Section: Toxicitymentioning
confidence: 98%
“…Seiler observed anaemia in dogs after prolonged treatment with TBZ [50]. In calves, treatment with cambendazole caused pulmonary oedema and necrotic lymphadenopathy, which was fatal in some cases [51].…”
Section: Toxicitymentioning
confidence: 98%
“…Mebendazole [methyl 5-benzoyl-2-benzimidazole carbamate] (Vermox; Janssen) was reported to be inactive against the infective larvae in immunosuppressed dogs, and has little effect on the parasite in muscle tissue of mice (Grove, 1982 a ). Use of cambendazole ([5-isopropoxycarbonylamino-2-(4-thiazyl) benzimidazole] (Merck, Sharp & Dohme) has been banned as a result of its linkage to several fatal idiosyncratic reactions in cattle (Hogg, 1978; Main and Vass, 1980).…”
Section: Introductionmentioning
confidence: 99%
“…Mebendazole [methyl 5-benzoyl-2-benzimidazole carbamate] (Vermox; Janssen) was reported to be inactive against the infective larvae in immunosuppressed dogs, and has little effect on the parasite in muscle tissue of mice (Grove, 1982a). Use of cambendazole ([5-isopropoxycarbonylamino-2-(4thiazyl) benzimidazole] (Merck, Sharp & Dohme) has been banned as a result of its linkage to several fatal idiosyncratic reactions in cattle (Hogg, 1978;Main and Vass, 1980). Alternatively, ivermectin [22,23-dihydroavermectin B 1 ] (Merck, Sharp & Dohme), a broad-spectrum, commercial drug (Fisher, 1985;Grove, 1989) that is a synthetic, lipophilic, macrocyclic lactone (Gustafsson et al 1987;Campbell, 1989), bears promise as an efficacious treatment against strongyloidosis (Naquira et al 1989;Marti et al 1996).…”
Section: Introductionmentioning
confidence: 99%